Assessing differences in mortality rates and risk factors between hispanic and non-hispanic patients with cystic fibrosis in California

Chest

Volumn 149, Issue 2, 2016, Pages 380-389

  Buu, MyMy C ^a   Sanders, Lee M ^a   Mayo, Jonathan A ^a   Milla, Carlos E ^a   Wise, Paul H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cystic fibrosis; Ethnicity; Health disparities; Pediatric pulmonology

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ARTICLE; BODY MASS; CFTR GENE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENOTYPE; HEALTH CARE ACCESS; HEALTH DISPARITY; HEALTH LITERACY; HISPANIC; HUMAN; INFECTION RATE; LIFE EXPECTANCY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON HISPANIC; ONSET AGE; PATIENT CODING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SOCIAL ASPECT; SOCIOECONOMICS; SURVIVAL RATE; SURVIVAL TIME; UNITED STATES; VULNERABLE POPULATION; YOUNG ADULT; ADOLESCENT; CALIFORNIA; CAUCASIAN; CHILD; EPIDEMIOLOGY; FOLLOW UP; INFANT; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PREVALENCE; PROCEDURES; REGISTER; TRENDS;

ADOLESCENT; CALIFORNIA; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HISPANIC AMERICANS; HUMANS; INFANT; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; SURVIVAL RATE;

EID: 84958093094     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-2189     Document Type: Article

References (46)

1. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J. 2007;29(3):522-526.
2. Cystic Fibrosis Foundation Patient Registry. 2010 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation; 2011.
3. Cystic Fibrosis Foundation Patient Registry. 2012 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation; 2013.
4. Mahadeva R, Webb K, Westerbeek RC, et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ. 1998;316(7147):1771-1775.
5. Lebecque P, Leonard A, De Boeck K, et al. Early referral to cystic fibrosis specialist centre impacts on respiratory outcome. J Cyst Fibros. 2009;8(1):26-30.
6. Nielsen OH, Thomsen BL, Green A, Andersen PK, Hauge M, Schiøtz PO. Cystic fibrosis in Denmark 1945 to 1985. An analysis of incidence, mortality and influence of centralized treatment on survival. Acta Paediatr Scand. 1988;77(6): 836-841.
7. Barr HL, Britton J, Smyth AR, Fogarty AW. Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional study. BMJ. 2011;343:d4662.
8. Schechter MS, Shelton BJ, Margolis PA, Fitzsimmons SC. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med. 2001;163(6):1331-1337.
9. Ngui EM, Flores G. Satisfaction with care and ease of using health care services among parents of children with special health care needs: the roles of race/ethnicity, insurance, language, and adequacy of family-centered care. Pediatrics. 2006;117(4):1184-1196.
10. Bradshaw M, Tomany-Korman S, Flores G. Language barriers to prescriptions for patients with limited English proficiency: a survey of pharmacies. Pediatrics. 2007;120(2): e225-e235.
11. Flores G, Abreu M, Tomany-Korman SC. Limited English proficiency, primary language at home, and disparities in children's health care: how language barriers are measured matters. Public Health Rep. 2005;120(4):418-430.
12. Shone LP, Conn KM, Sanders L, Halterman JS. The role of parent health literacy among urban children with persistent asthma. Patient Educ Couns. 2009;75(3):368-375.
13. Schrijver I, Ramalingam S, Sankaran R, et al. Diagnostic testing by CFTR gene mutation analysis in a large group of Hispanics: novel mutations and assessment of a population-specific mutation spectrum. J Mol Diagn. 2005;7(2):289-299.
14. Ennis SR, Rios-Vargas M, Albert NG; Department of Commerce. The Hispanic Population: 2010. 2010 Census Brief. Washington, DC: Government Printing Office; 2011.
15. Fitz Simmons SC. The changing epidemiology of cystic fibrosis. J Pediatr. 1993;122(1):1-9.
16. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983;127(6):725-734.
17. Sherrill DL, Lebowitz MD, Knudson RJ, Burrows B. Methodology for generating continuous prediction equations for pulmonary function measures. Comput Biomed Res. 1991;24(3):249-260.
18. Slieker MG, Uiterwaal CS, Sinaasappel M, Heijerman HG, van der Laag J, van der Ent CK. Birth prevalence and survival in cystic fibrosis: a national cohort study in the Netherlands. Chest. 2005;128(4): 2309-2315.
19. O'Connor GT, Quinton HB, Kahn R, et al; Northern New England Cystic Fibrosis Consortium. Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr Pulmonol. 2002;33(2):99-105.
20. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992;326(18):1187-1191.
21. McKone EF, Emerson SS, Edwards KL, Aitken ML. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet. 2003;361(9370):1671-1676.
22. Courtney JM, Bradley J, Mccaughan J, et al. Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol. 2007;42(6):525-532.
23. Ledson MJ, Gallagher MJ, Jackson M, Hart CA, Walshaw MJ. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax. 2002;57(2):142-145.
24. Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care. 2005;28(9):2141-2144.
25. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993;73(7):1251-1254.
26. Nixon GM, Armstrong DS, Carzino R, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr. 2001;138(5): 699-704.
27. Li Z, Kosorok MR, Farrell PM, et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA. 2005;293(5): 581-588.
28. Claritas, Inc. Population facts database 2004: United States demographics. http://tetrad.com/demographics/usa/ags/agshhfin.html. Accessed October 30, 2009.
29. Borowitz D, Robinson KA, Rosenfeld M, et al; Cystic Fibrosis Foundation. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 2009;155(Suppl 6): S73-S93.
30. Kerem E, Conway S, Elborn S, Heijerman H; Consensus Committee. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros. 2005;4(1):7-26.
31. Sosnay PR, Siklosi KR, Van Goor F, et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet. 2013;45(10):1160-1167.
32. Etches V, Frank J, Di Ruggiero E, Manuel D. Measuring population health: a review of indicators. Annu Rev Public Health. 2006;27:29-55.
33. Braveman PA, Egerter SA, Mockenhaupt RE. Broadening the focus: the need to address the social determinants of health. Am J Prev Med. 2011;40(suppl 1):S4-S18.
34. Accurso FJ, Rowe SM, Clancy JP, et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med. 2010;363(21): 1991-2003.
35. Taylor-Robinson DC, Smyth RL, Diggle PJ, Whitehead M. The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study. Lancet Respir Med. 2013;1(2):121-128.
36. Aber JL, Bennett NG, Conley DC, Li J. The effects of poverty on child health and development. Annu Rev Public Health. 1997;18(1):463-483.
37. Wilkinson R, Marmot M. Social Determinants of Health: The Solid Facts. 2nd ed. Copenhagen, Denmark: World Health Organization; 2003.
38. Watts KD, Seshadri R, Sullivan C, McColley SA. Increased prevalence of risk factors for morbidity and mortality in the US Hispanic CF population. Pediatr Pulmonol. 2009;44(6):594-601.
39. Cohen-Cymberknoh M, Shoseyov D, Kerem E. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. Am J Respir Crit Care Med. 2011;183(11):1463-1471.
40. Watts KD, Schechter MS. Origins of outcome disparities in pediatric respiratory disease. Pediatr Ann. 2010;39(12):793-798.
41. Farrell MH, Kuruvilla P. Assessment of parental understanding by pediatric residents during counseling after newborn genetic screening. Arch Pediatr Adolesc Med. 2008;162(3):199-204.
42. Bradby H. Race, ethnicity and health: the costs and benefits of conceptualising racism and ethnicity. Soc Sci Med. 2012;75(6):955-958.
43. Lee C. "Race" and "ethnicity" in biomedical research: how do scientists construct and explain differences in health? Soc Sci Med. 2009;68(6):1183-1190.
44. Anand SS. Using ethnicity as a classification variable in health research: perpetuating the myth of biological determinism, serving socio-political agendas, or making valuable contributions to medical sciences? Ethn Health. 1999;4(4):241-244.
45. Pearce N, Foliaki S, Sporle A, Cunningham C. Genetics, race, ethnicity, and health. BMJ. 2004;328(7447): 1070-1072.
46. Tramper-Stranders GA, van der Ent CK, Wolfs TF. Detection of Pseudomonas aeruginosa in patients with cystic fibrosis. J Cyst Fibros. 2005;4(suppl 2):37-43.